Andrea Baker

405 total citations
29 papers, 279 citations indexed

About

Andrea Baker is a scholar working on Psychiatry and Mental health, Physiology and Experimental and Cognitive Psychology. According to data from OpenAlex, Andrea Baker has authored 29 papers receiving a total of 279 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Psychiatry and Mental health, 7 papers in Physiology and 5 papers in Experimental and Cognitive Psychology. Recurrent topics in Andrea Baker's work include Schizophrenia research and treatment (14 papers), Diet and metabolism studies (7 papers) and Amino Acid Enzymes and Metabolism (4 papers). Andrea Baker is often cited by papers focused on Schizophrenia research and treatment (14 papers), Diet and metabolism studies (7 papers) and Amino Acid Enzymes and Metabolism (4 papers). Andrea Baker collaborates with scholars based in Australia, Denmark and United Kingdom. Andrea Baker's co-authors include Declan C. Schroeder, Dan Siskind, Willi Kreis, A Bertasso, James G. Scott, John P. Blass, Mark A. Moline, Ian Robbins, Silvia Piacentini and M. Débora Iglesias‐Rodríguez and has published in prestigious journals such as SHILAP Revista de lepidopterología, Journal of Neurochemistry and JAMA Psychiatry.

In The Last Decade

Andrea Baker

24 papers receiving 271 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Andrea Baker Australia	11	77	72	54	45	44	29	279
Patricia Jumbo‐Lucioni United States	14	206 2.7×	39 0.5×	79 1.5×	35 0.8×	163 3.7×	24	546
Amanda S. Souza Brazil	11	47 0.6×	16 0.2×	15 0.3×	11 0.2×	50 1.1×	16	319
Kulbir Kaur India	8	199 2.6×	79 1.1×	7 0.1×	25 0.6×	67 1.5×	33	616
Fatma Atig Tunisia	6	42 0.5×	77 1.1×	33 0.6×	9 0.2×	36 0.8×	9	447
Anibal A. Arjona United States	6	85 1.1×	47 0.7×	4 0.1×	32 0.7×	153 3.5×	6	438
See-Ziau Hoe Malaysia	13	170 2.2×	13 0.2×	9 0.2×	7 0.2×	23 0.5×	43	427
Ana B. Hitos Spain	9	134 1.7×	12 0.2×	22 0.4×	10 0.2×	80 1.8×	18	399
Sirpa Pennanen Finland	9	61 0.8×	27 0.4×	8 0.1×	11 0.2×	27 0.6×	22	365
Frederik Dethloff Germany	11	238 3.1×	16 0.2×	16 0.3×	5 0.1×	44 1.0×	20	395
Jon M. Reed United States	10	156 2.0×	120 1.7×	5 0.1×	21 0.5×	52 1.2×	10	368

Countries citing papers authored by Andrea Baker

Since Specialization

Citations

This map shows the geographic impact of Andrea Baker's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andrea Baker with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andrea Baker more than expected).

Fields of papers citing papers by Andrea Baker

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Andrea Baker. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andrea Baker. The network helps show where Andrea Baker may publish in the future.

Co-authorship network of co-authors of Andrea Baker

This figure shows the co-authorship network connecting the top 25 collaborators of Andrea Baker. A scholar is included among the top collaborators of Andrea Baker based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Andrea Baker. Andrea Baker is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Arnautovska, Urška, Andrea Baker, Ingrid J. Hickman, et al.. (2025). Schizophrenia, Nutrition and Choices in Kilojoules (SNaCK): protocol for a feasibility and acceptability randomised controlled trial of two dietary interventions. BJPsych Open. 11(4). e159–e159.

Arnautovska, Urška, et al.. (2025). Research Letter: Using participatory approach to facilitate engagement of people with lived experience of schizophrenia in research: A co-designed Participant Information and Consent Form. Australian & New Zealand Journal of Psychiatry. 3681990275–3681990275.

Korman, Nicole, Robert Stanton, Mike Trott, et al.. (2025). The feasibility of resistance training versus aerobic exercise in a rehabilitation setting for people living with psychotic disorders: A randomised controlled trial. Australian & New Zealand Journal of Psychiatry. 3681963409–3681963409. 1 indexed citations

Arnautovska, Urška, Natasha Reid, Andrea Baker, et al.. (2025). Outcomes of a pilot feasibility study of comprehensive geriatric assessment for younger frail patients with severe mental illness. BMC Psychiatry. 25(1). 473–473.

Siskind, Dan, Andrea Baker, Urška Arnautovska, et al.. (2025). Efficacy and safety of semaglutide versus placebo for people with schizophrenia on clozapine with obesity (COaST): a phase 2, multi-centre, participant and investigator- blinded, randomised controlled trial in Australia. The Lancet Psychiatry. 12(7). 493–503. 6 indexed citations

Arnautovska, Urška, Nicole Korman, Alyssa Milton, et al.. (2025). A Novel Digital Intervention to Facilitate Diabetes Self-Management Among People with Schizophrenia and Related Disorders: Development and Acceptability Testing of SMART. Neuropsychiatric Disease and Treatment. Volume 21. 1289–1305.

Siskind, Dan, Claudia Bull, Shuichi Suetani, et al.. (2024). Protocol for Cancloz: multicentre randomised, placebo-controlled, double-blind, parallel-group adaptive trial of cannabidiol for clozapine-resistant schizophrenia. BJPsych Open. 10(5). e156–e156.

Siskind, Dan, Andrea Baker, Anthony Russell, et al.. (2023). Effects of semaglutide on body weight in clozapine-treated people with schizophrenia and obesity: study protocol for a placebo-controlled, randomised multicentre trial (COaST). BJPsych Open. 9(4). 7 indexed citations

Arnautovska, Urška, Dan Siskind, Andrea Baker, et al.. (2023). Comprehensive Geriatric Assessment for younger outpatients with severe mental illness: protocol for a feasibility study. BMJ Open. 13(2). e069518–e069518. 5 indexed citations

10.

Baker, Andrea, Kelly Garner, Dan Siskind, et al.. (2022). Impairments in goal-directed action and reversal learning in a proportion of individuals with psychosis. Cognitive Affective & Behavioral Neuroscience. 22(6). 1390–1403. 13 indexed citations

11.

Marx, Wolfgang, David Skvarc, Mohammadreza Mohebbi, et al.. (2021). The Effect of Adjunctive Mangosteen Pericarp on Cognition in People With Schizophrenia: Secondary Analysis of a Randomized Controlled Trial. Frontiers in Psychiatry. 12. 626486–626486. 4 indexed citations

12.

Baker, Andrea, Peter Donovan, Jacobus Ungerer, et al.. (2021). Cadence discovery: study protocol for a dose-finding and mechanism of action clinical trial of sodium benzoate in people with treatment-refractory schizophrenia. Trials. 22(1). 918–918. 3 indexed citations

13.

Dark, Frances, James G. Scott, Andrea Baker, et al.. (2020). Randomized controlled trial of social cognition and interaction training compared to befriending group. British Journal of Clinical Psychology. 59(3). 384–402. 11 indexed citations

14.

Turner, Alyna, Andrea Baker, Olivia Dean, et al.. (2020). Adjunctive Garcinia mangostana Linn. (Mangosteen) Pericarp for Schizophrenia: A 24-Week Double-blind, Randomized, Placebo Controlled Efficacy Trial: Péricarpe d’appoint Garcinia mangostana Linn (mangoustan) pour la schizophrénie : un essai d’efficacité de 24 semaines, à double insu, randomisé et contrôlé par placebo. The Canadian Journal of Psychiatry. 66(4). 354–366. 5 indexed citations

15.

Scott, James G., Andrea Baker, Carmen Lim, et al.. (2020). Effect of Sodium Benzoate vs Placebo Among Individuals With Early Psychosis. JAMA Network Open. 3(11). e2024335–e2024335. 26 indexed citations

16.

Lim, Carmen, Andrea Baker, Sukanta Saha, et al.. (2019). Protocol update and statistical analysis plan for CADENCE-BZ: a randomized clinical trial to assess the efficacy of sodium benzoate as an adjunctive treatment in early psychosis. Trials. 20(1). 203–203. 2 indexed citations

17.

Baker, Andrea, Frances Dark, Sharon Foley, et al.. (2017). The efficacy of sodium benzoate as an adjunctive treatment in early psychosis - CADENCE-BZ: study protocol for a randomized controlled trial. Trials. 18(1). 165–165. 10 indexed citations

18.

Baker, Andrea, Ian Robbins, Mark A. Moline, & M. Débora Iglesias‐Rodríguez. (2008). OLIGONUCLEOTIDE PRIMERS FOR THE DETECTION OF BIOLUMINESCENT DINOFLAGELLATES REVEAL NOVEL LUCIFERASE SEQUENCES AND INFORMATION ON THE MOLECULAR EVOLUTION OF THIS GENE¹. Journal of Phycology. 44(2). 419–428. 19 indexed citations

19.

Baker, Andrea & Declan C. Schroeder. (2008). Occurrence and genetic analysis of picorna-like viruses infecting worker bees of Apis mellifera L. populations in Devon, South West England. Journal of Invertebrate Pathology. 98(2). 239–242. 43 indexed citations

20.

Baker, Andrea, et al.. (1955). Vitamin C for the prevention of winter absence in industry.. Medical officer. 93. 31–32. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact